Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at SEK 958B, ahead of Eli Lilly (SEK 662.9B) and Merck & Co (SEK 661.2B). Figures as of 19 Nov 2026, 00:04 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonSEK 958B
- Median
- SEK 32.6B
- Combined market value
- SEK 51.45T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SEK 958B | SEK 6.68T | SEK 2,773.41 | 2.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SEK 662.9B | SEK 12.53T | SEK 14,062.80 | 2.32% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SEK 661.2B | SEK 3.45T | SEK 1,401.25 | 3.90% down | 51% up | ||
| 4 | PfizerPFE · Health Care | SEK 636.4B | SEK 1.63T | SEK 285.37 | 1.44% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | SEK 622B | SEK 5.14T | SEK 2,908.77 | 2.33% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | SEK 597.4B | SEK 2.82T | SEK 1,818.02 | 1.93% down | 2% up | ||
| 7 | NovartisNVS · Health Care | SEK 554.6B | SEK 2.98T | SEK 1,578.51 | 2.46% down | 25% up | ||
| 8 | SanofiSNY · Health Care | SEK 492.3B | SEK 1.15T | SEK 479.22 | 0.86% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | SEK 490.1B | SEK 1.24T | SEK 605.74 | 2.92% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | SEK 466.4B | SEK 1.77T | SEK 401.01 | 3.12% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | SEK 450.8B | SEK 1.84T | SEK 1,062.58 | 0.22% down | 17% down | ||
| 12 | GSKGSK · Health Care | SEK 441B | SEK 990.3B | SEK 494.07 | 1.34% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | SEK 287B | SEK 691.1B | SEK 216.32 | 1.71% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 175.5B | SEK 501.1B | SEK 429.49 | 0.92% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | SEK 145.9B | SEK 994.8B | SEK 9,616.20 | 1.28% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | SEK 145.4B | SEK 236.5B | SEK 206.25 | 0.83% down | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | SEK 122.1B | SEK 1.38T | SEK 5,455.79 | 0.42% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | SEK 96.3B | SEK 353.6B | SEK 870.26 | 2.50% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | SEK 84.9B | SEK 58.6B | SEK 86.14 | 1.85% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | SEK 54.3B | SEK 468.9B | SEK 4,104.68 | 2.34% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | SEK 48B | SEK 135.7B | SEK 271.54 | 3.29% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 43.4B | SEK 161.7B | SEK 2,519.86 | 2.93% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | SEK 37.8B | SEK 319.6B | SEK 518.37 | 1.91% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SEK 37.8B | SEK 203.5B | SEK 1,519.42 | 4.54% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 36.4B | SEK 127B | SEK 152.35 | 1.28% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | SEK 32.8B | SEK 121B | SEK 624.75 | 4.99% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | SEK 32.4B | SEK 250.1B | SEK 5,871.65 | 1.16% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | SEK 30.7B | SEK 77.5B | SEK 222.52 | 3.60% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | SEK 24.2B | SEK 401.6B | SEK 698.39 | 0.01% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | SEK 17.6B | SEK 51.2B | SEK 612.55 | 0.22% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | SEK 15B | SEK 80.1B | SEK 476.47 | 3.08% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | SEK 10.5B | SEK 32.1B | SEK 165.27 | 0.87% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 9.7B | SEK 94B | SEK 4,048.54 | 5.67% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | SEK 9.6B | SEK 46.4B | SEK 278.56 | 1.59% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 8.4B | SEK 62B | SEK 438.44 | 0.28% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | SEK 8.1B | SEK 180.3B | SEK 2,749.30 | 0.32% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | SEK 7.7B | SEK 75.5B | SEK 689.44 | 3.25% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 6.9B | SEK 76B | SEK 966.67 | 0.06% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | SEK 6.5B | SEK 71.7B | SEK 1,362.80 | 1.43% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | SEK 6.3B | SEK 101.6B | SEK 672.45 | 5.44% up | 107% up | ||
| 41 | InsmedINSM · Health Care | SEK 6.2B | SEK 267.3B | SEK 1,218.39 | 1.69% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.3B | SEK 61.4B | SEK 940.64 | 0.59% up | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | SEK 5.1B | SEK 154.6B | SEK 793.37 | 1.58% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 49B | SEK 510.95 | 1.68% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | SEK 2.7B | SEK 60.8B | SEK 3,037.93 | 1.67% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.9B | SEK 83.9B | SEK 1,210.66 | 2.08% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | SEK 895.4M | SEK 72.7B | SEK 521.93 | 0.64% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | SEK 468M | SEK 84.4B | SEK 1,293.24 | 2.00% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | SEK 84M | SEK 285.4B | SEK 393.89 | 0.05% up | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | SEK 20.7M | SEK 48.1B | SEK 854.09 | 3.45% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | SEK 0 | SEK 98B | SEK 1,031.87 | 8.15% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | SEK 0 | SEK 86.8B | SEK 3,103.83 | 0.04% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1702 SEK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (SEK 958B), Eli Lilly (SEK 662.9B) and Merck & Co (SEK 661.2B) are the top three of the 52 pharmaceutical companies ranked by revenue as of 19 Nov 2026, 00:04 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of SEK 51.45T as of 19 Nov 2026, 00:04 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.